Longwood Biopharmaceuticals
As of the edition of 20 October 2026, Longwood Biopharmaceuticals runs 2 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 2 |
| Total | 2 |
Where its trials are
- Immune system: 3 trials led
- Skin and connective tissue: 3 trials led
- Digestive system: 2 trials led